[Correlation of the microbiota and intestinal mucosa in the pathophysiology and treatment of irritable bowel, irritable eye, and irritable mind syndrome]. Review uri icon

Overview

abstract

  • Accumulating clinical evidence supports co-morbidity of irritable bowel, irritable eye and irritable mind symptoms. Furthermore, perturbation of the microbiota-host symbiosis (dysbiosis) is considered a common pathogenic mechanism connecting gastrointestinal, ocular and neuropsychiatric symptoms. Consequently, maintaining or restoring microbiota-host symbiosis represents a new approach to treat these symptoms or to prevent their relapses. Current treatment approach assigned a primary role to live probiotics alone or in combination with prebiotics to enhance colonization of beneficial bacteria and to strengthen the symbiosis. However, several papers showed major benefits of heat-killed probiotics as compared to their live counterparts on both intestinal and systemic symptoms. Recently, in addition to killing probiotics, in a proof of concept study lysates (fragments) of probiotics in combination with vitamins A, B, D and omega 3 fatty acids were successfully tested. These findings suggested a conceptual change in the approach addressed to both the microbiota and host as targets for intervention.

publication date

  • September 14, 2014

Research

keywords

  • Eye Diseases
  • Intestinal Mucosa
  • Irritable Bowel Syndrome
  • Irritable Mood
  • Microbiota
  • Mood Disorders
  • Probiotics

Identity

Scopus Document Identifier

  • 84907015382

Digital Object Identifier (DOI)

  • 10.1556/OH.2014.29987

PubMed ID

  • 25194867

Additional Document Info

volume

  • 155

issue

  • 37